GHO Capital and The Vistria Group completed the acquisition of a majority stake in Alcami from Madison Dearborn and Ampersand Capital.

GHO Capital, a healthcare investment adviser, and The Vistria Group, a private equity firm, completed the acquisition of a majority stake in Alcami, a pharmaceutical contract development and manufacturing organization, from two private equity firms Madison Dearborn and Ampersand Capital. Financial terms were not disclosed. "This is an ideal partnership in furthering Alcami’s strategic transformation, unprecedented growth rate and comprehensive service offerings valued by over 1k clients around the globe. GHO and The Vistria Group have excellent reputations for partnering with high growth companies that create value for all stakeholders. We want to thank the MDP and Ampersand teams for their strong leadership and support of Alcami over the last several years and we look forward to further scaling our offering, capacity and geographic reach with our new partners," Patrick Walsh, Alcami Chairman and CEO.